{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:41:44Z","timestamp":1789170104495,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"VCCC Alliance"},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"crossref","award":["MRF1199701"],"award-info":[{"award-number":["MRF1199701"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Palliative radiotherapy (PRT) is crucial for improving quality of life in patients with advanced-staged cancer. This large data analysis investigates the travel distances and potential disparities in PRT access especially focusing on the burden of excess travel for palliative cancer patients in Victoria, Australia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a state-wide linked dataset from the PRedicting the health economic IMPact of new and current Cancer Treatments (PRIMCAT) research program, we analysed the estimated road travel distance (ERTD) and potential excess travel distance (PETD) as well as received radiotherapy fractions for 29,807 PRT patients being treated from 2010\u20132019. We examined disparities by socioeconomic status (SEIFA) and remoteness (RA) of the residential area of PRT patients, and receiving treatment at a public or private centre.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The average one-way ERTD for all PRT patients was 43 km, with variations based on SEIFA and RA. Patients in the lowest SEIFA quintile and those living in outer regional areas had the longest ERTD. Approximately 50% did not receive treatment at the closest facility, with a mean PETD of 27.9 km for private and 24.3 km for public facility patients. Fractionation patterns showed no significant reduction in the number of fractions with increased travel distance. Patients at private facilities received more fractions on average (8.49) compared to those at public facilities (5.91).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights potential disparities in PRT access in Victoria, with patients living in socioeconomically disadvantaged and remote regions facing longer travel distances and excess travel. These findings underscore the need for strategic referral practices and further research to optimise equitable access to PRT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-025-02418-8","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:42:23Z","timestamp":1755877343000},"page":"1296-1305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Travel distance and potential disparities in palliative radiotherapy access for cancer patients in Victoria, Australia"],"prefix":"10.1007","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-4273","authenticated-orcid":false,"given":"Maike","family":"Trommer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piers","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Franchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hornby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skye","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dishan","family":"Herath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Gough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Donohoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Foroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"10128","key":"2418_CR1","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","volume":"391","author":"FM Knaul","year":"2018","unstructured":"Knaul\u00a0FM, Farmer\u00a0PE, Krakauer\u00a0EL, De Lima\u00a0L, Bhadelia\u00a0A, Kwete\u00a0JX et\u00a0al (2018) Alleviating the access abyss in palliative care and pain relief\u2014an imperative of universal health coverage: the lancet commission report. Lancet 391(10128):1391\u20131454","journal-title":"Lancet"},{"issue":"2","key":"2418_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.clon.2011.11.004","volume":"24","author":"E Chow","year":"2012","unstructured":"Chow\u00a0E, Zeng\u00a0L, Salvo\u00a0N, Dennis\u00a0K, Tsao\u00a0M, Lutz\u00a0S (2012) Update on the systematic review of palliative radiotherapy trials for bone metastases. Clin Oncol 24(2):112\u2013124","journal-title":"Clin Oncol"},{"issue":"11","key":"2418_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/jnci\/dji139","volume":"97","author":"WF Hartsell","year":"2005","unstructured":"Hartsell\u00a0WF, Scott\u00a0CB, Bruner\u00a0DW, Scarantino\u00a0CW, Ivker\u00a0RA, Roach\u00a0M 3rd et\u00a0al (2005) Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J\u00a0Natl Cancer Inst 97(11):798\u2013804","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2418_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.radonc.2018.01.003","volume":"126","author":"SE Rich","year":"2018","unstructured":"Rich\u00a0SE, Chow\u00a0R, Raman\u00a0S, Zeng\u00a0LK, Lutz\u00a0S, Lam\u00a0H et\u00a0al (2018) Update of the systematic review of palliative radiation therapy fractionation for bone metastases. Radiother Oncol 126(3):547\u2013557","journal-title":"Radiother Oncol"},{"issue":"3","key":"2418_CR5","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.soc.2021.02.007","volume":"30","author":"GR Williams","year":"2021","unstructured":"Williams\u00a0GR, Manjunath\u00a0SH, Butala\u00a0AA, Jones\u00a0JA (2021) Palliative radiotherapy for advanced cancers: indications and outcomes. Surg Oncol Clin N Am 30(3):563\u2013580","journal-title":"Surg Oncol Clin N Am"},{"issue":"1","key":"2418_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13014-021-01900-8","volume":"16","author":"K Yamaguchi","year":"2021","unstructured":"Yamaguchi\u00a0K, Saito\u00a0T, Toya\u00a0R, Tomitaka\u00a0E, Matsuyama\u00a0T, Fukugawa\u00a0Y et\u00a0al (2021) Palliative radiotherapy for painful lymph node metastases. Radiat Oncol 16(1):178","journal-title":"Radiat Oncol"},{"issue":"5","key":"2418_CR7","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/j.prro.2015.02.008","volume":"5","author":"C Nieder","year":"2015","unstructured":"Nieder\u00a0C, Haukland\u00a0E, Mannsaker\u00a0B, Pawinski\u00a0A, Dalhaug\u00a0A (2015) Early palliative radiation therapy in patients with newly diagnosed cancer: reasons, clinical practice, and survival. Pract Radiat Oncol 5(5):e537\u2013e542","journal-title":"Pract Radiat Oncol"},{"key":"2418_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1748-717X-8-85","volume":"8","author":"C Nieder","year":"2013","unstructured":"Nieder\u00a0C, Pawinski\u00a0A, Dalhaug\u00a0A (2013) Continuous controversy about radiation oncologists\u2019 choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies? Radiat Oncol 8:85","journal-title":"Radiat Oncol"},{"issue":"1","key":"2418_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13014-020-01737-7","volume":"16","author":"D Rades","year":"2021","unstructured":"Rades\u00a0D, Cacicedo\u00a0J, Conde-Moreno\u00a0AJ, Segedin\u00a0B, Lomidze\u00a0D, Ciervide\u00a0R et\u00a0al (2021) Comparison of 5 x 5\u202fGy and 10 x 3\u202fGy for metastatic spinal cord compression using data from three prospective trials. Radiat Oncol 16(1):7","journal-title":"Radiat Oncol"},{"key":"2418_CR10","doi-asserted-by":"crossref","unstructured":"Chand CP, Greenley S, Macleod U, Lind M, Barton R, Kelly C (2022) Geographical distance and reduced access to palliative radiotherapy: systematic review and meta-analysis. BMJ Support Palliat Care","DOI":"10.1136\/bmjspcare-2021-003356"},{"issue":"1","key":"2418_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1472-684X-13-49","volume":"13","author":"J Huang","year":"2014","unstructured":"Huang\u00a0J, Wai\u00a0ES, Lau\u00a0F, Blood\u00a0PA (2014) Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study. BMC Palliat Care 13(1):49","journal-title":"BMC Palliat Care"},{"issue":"4","key":"2418_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s00066-017-1240-8","volume":"194","author":"B Zurl","year":"2018","unstructured":"Zurl\u00a0B, Bayerl\u00a0A, De Vries\u00a0A, Geinitz\u00a0H, Hawliczek\u00a0R, Knocke-Abulesz\u00a0TH et\u00a0al (2018) OGRO survey on radiotherapy capacity in Austria : status quo and estimation of future demands. Strahlenther Onkol 194(4):284\u2013292","journal-title":"Strahlenther Onkol"},{"key":"2418_CR13","unstructured":"Department of Health & Human Services (2022) Victorian radiotherapy minimum data set. https:\/\/www.health.vic.gov.au\/publications\/victorian-radiotherapy-minimum-data-set-user-manual-and-appendices"},{"key":"2418_CR14","volume-title":"Rstudio: integrated development environment for R","author":"Posit team","year":"2023","unstructured":"Posit team (2023) Rstudio: integrated development environment for R. Posit Software, PBC, Boston, MA"},{"key":"2418_CR15","volume-title":"R: a\u00a0language and environment for statistical computing","author":"R Core Team","year":"2023","unstructured":"R Core Team (2023) R: a\u00a0language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria"},{"key":"2418_CR16","volume-title":"gmapsdistance: distance and travel time between two points from Google maps","author":"RA Melo","year":"2023","unstructured":"Melo\u00a0RA, Zarruk\u00a0D (2023) gmapsdistance: distance and travel time between two points from Google maps"},{"key":"2418_CR17","unstructured":"Cancer Institute NSW (2024) eviQ. https:\/\/www.eviq.org.au"},{"key":"2418_CR18","unstructured":"Australian Bureau of Statistics Remoteness areas canberra: aBS; Jul2021-Jun2026. https:\/\/www.abs.gov.au\/statistics\/standards\/australian-statistical-geography-standard-asgs-edition-3\/jul2021-jun2026\/remoteness-structure\/remoteness-areas"},{"key":"2418_CR19","unstructured":"Australian Bureau of Statistics Socio-economic indexes for areas (SEIFA), Australia canberra2021. https:\/\/www.abs.gov.au\/statistics\/people\/people-and-communities\/socio-economic-indexes-areas-seifa-australia\/latest-release"},{"issue":"e1","key":"2418_CR20","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1136\/bmjspcare-2021-003356","volume":"14","author":"CP Chand","year":"2024","unstructured":"Chand\u00a0CP, Greenley\u00a0S, Macleod\u00a0U, Lind\u00a0M, Barton\u00a0R, Kelly\u00a0C (2024) Geographical distance and reduced access to palliative radiotherapy: systematic review and meta-analysis. BMJ Support & Palliat Care 14(e1):e89\u2013e98","journal-title":"BMJ Support & Palliat Care"},{"issue":"2","key":"2418_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.radonc.2015.07.031","volume":"117","author":"G Gabriel","year":"2015","unstructured":"Gabriel\u00a0G, Barton\u00a0M, Delaney\u00a0GP (2015) The effect of travel distance on radiotherapy utilization in NSW and ACT. Radiother Oncol 117(2):386\u2013389","journal-title":"Radiother Oncol"},{"key":"2418_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.radonc.2019.09.012","volume":"141","author":"R Merie","year":"2019","unstructured":"Merie\u00a0R, Gabriel\u00a0G, Shafiq\u00a0J, Vinod\u00a0S, Barton\u00a0M, Delaney\u00a0GP (2019) Radiotherapy underutilisation and its impact on local control and survival in new south Wales, Australia. Radiother Oncol 141:41\u201347","journal-title":"Radiother Oncol"},{"issue":"5","key":"2418_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.clon.2020.01.007","volume":"32","author":"ML Yap","year":"2020","unstructured":"Yap\u00a0ML, O\u2019Connell\u00a0DL, Goldsbury\u00a0D, Weber\u00a0M, Barton\u00a0M (2020) Factors associated with radiotherapy Utilisation in new south Wales, Australia: results from the 45 and up study. Clin Oncol 32(5):282\u2013291","journal-title":"Clin Oncol"},{"issue":"10162","key":"2418_CR24","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","volume":"392","author":"CC Parker","year":"2018","unstructured":"Parker\u00a0CC, James\u00a0ND, Brawley\u00a0CD, Clarke\u00a0NW, Hoyle\u00a0AP, Ali\u00a0A et\u00a0al (2018) Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a\u00a0randomised controlled phase\u00a03\u00a0trial. Lancet 392(10162):2353\u20132366","journal-title":"Lancet"},{"issue":"4","key":"2418_CR25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ijrobp.2022.05.004","volume":"114","author":"S Harrow","year":"2022","unstructured":"Harrow\u00a0S, Palma\u00a0DA, Olson\u00a0R, Gaede\u00a0S, Louie\u00a0AV, Haasbeek\u00a0C et\u00a0al (2022) Stereotactic radiation for the comprehensive treatment of Oligometastases (SABR-COMET): extended long-term outcomes. Int J Radiat Oncol Biol Phys 114(4):611\u2013616","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2418_CR26","unstructured":"Australian Institute of Health Welfare (2020) Radiotherapy in Australia 2018\u201319 canberra: AIHW. https:\/\/www.aihw.gov.au\/reports\/radiotherapy\/radiotherapy-in-australia-2018-19"},{"issue":"6","key":"2418_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jpainsymman.2020.06.021","volume":"60","author":"A Vargas","year":"2020","unstructured":"Vargas\u00a0A, Torres\u00a0C, Kuller-Bosch\u00a0A, Villena\u00a0B (2020) Radiotherapy in Australia 2018\u201319 canberra: AIHW. J\u00a0Pain Symptom Manage 60(6):1193\u20131199 (e3)","journal-title":"J Pain Symptom Manage"},{"key":"2418_CR28","doi-asserted-by":"crossref","unstructured":"Leiss SM, Hou HX, Pigorsch S, Borm K, Peeken J, Schneider A et\u00a0al (2025) Analysis of radiation oncology integration within general practitioners\u2019 daily patient care: a\u00a0cross-sectional survey in Germany. Strahlenther Onkol","DOI":"10.1007\/s00066-024-02352-1"},{"issue":"1","key":"2418_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1186\/s12885-017-3790-7","volume":"17","author":"SC Thompson","year":"2017","unstructured":"Thompson\u00a0SC, Cheetham\u00a0S, Baxi\u00a0S (2017) The enablers, barriers and preferences of accessing radiation therapy facilities in the rural developed world\u2014a\u00a0systematic review. BMC Cancer 17(1):794","journal-title":"BMC Cancer"},{"key":"2418_CR30","doi-asserted-by":"publisher","first-page":"110092","DOI":"10.1016\/j.radonc.2024.110092","volume":"192","author":"L Han","year":"2024","unstructured":"Han\u00a0L, Sullivan\u00a0R, Tree\u00a0A, Lewis\u00a0D, Price\u00a0P, Sangar\u00a0V et\u00a0al (2024) The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: A\u00a0national population-based evaluation. Radiother Oncol 192:110092","journal-title":"Radiother Oncol"},{"issue":"3","key":"2418_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/jrh.12413","volume":"36","author":"CF Longacre","year":"2020","unstructured":"Longacre\u00a0CF, Neprash\u00a0HT, Shippee\u00a0ND, Tuttle\u00a0TM, Virnig\u00a0BA (2020) Evaluating travel distance to radiation facilities among rural and Urban breast cancer patients in the medicare population. J\u00a0Rural Health 36(3):334\u2013346","journal-title":"J Rural Health"},{"issue":"6","key":"2418_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.prro.2014.06.003","volume":"4","author":"C Hahn","year":"2014","unstructured":"Hahn\u00a0C, Kavanagh\u00a0B, Bhatnagar\u00a0A, Jacobson\u00a0G, Lutz\u00a0S, Patton\u00a0C et\u00a0al (2014) Choosing wisely: the American Society for Radiation Oncology\u2019s top 5 list. Pract Radiat Onc 4(6):349\u2013355","journal-title":"Pract Radiat Onc"},{"issue":"5","key":"2418_CR33","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1089\/jpm.2011.0512","volume":"15","author":"ST Lutz","year":"2012","unstructured":"Lutz\u00a0ST, Lo\u00a0SS, Chang\u00a0EL, Galanopoulos\u00a0N, Expert Panel On Radiation Oncology-Bone M et\u00a0al (2012) ACR appropriateness criteria(R) non-spine bone metastases. J\u00a0Palliat Med 15(5):521\u2013526","journal-title":"J Palliat Med"},{"issue":"4","key":"2418_CR34","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ijrobp.2010.11.026","volume":"79","author":"S Lutz","year":"2011","unstructured":"Lutz\u00a0S, Berk\u00a0L, Chang\u00a0E, Chow\u00a0E, Hahn\u00a0C, Hoskin\u00a0P et\u00a0al (2011) Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 79(4):965\u2013976","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2418_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijrobp.2019.08.061","volume":"106","author":"WL Ong","year":"2020","unstructured":"Ong\u00a0WL, Foroudi\u00a0F, Milne\u00a0RL, Millar\u00a0JL (2020) Variation in the use of single- versus Multifraction palliative radiation therapy for Bone metastases in Australia. Int J Radiat Oncol Biol Phys 106(1):61\u201366","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2418_CR36","doi-asserted-by":"crossref","unstructured":"Kitaw TA, Tilahun BD, Zemariam AB, Getie A, Bizuayehu MA, Haile RN (2025) The financial toxicity of cancer: unveiling global burden and risk factors\u2014a\u00a0systematic review and meta-analysis. BMJ Glob Health 10(2)","DOI":"10.1136\/bmjgh-2024-017133"},{"issue":"12","key":"2418_CR37","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00066-022-01936-z","volume":"198","author":"A Fabian","year":"2022","unstructured":"Fabian\u00a0A, Domschikowski\u00a0J, Greiner\u00a0W, Bockelmann\u00a0G, Karsten\u00a0E, Ruhle\u00a0A et\u00a0al (2022) Financial toxicity in cancer patients treated with radiotherapy in Germany\u2014a cross-sectional study. Strahlenther Onkol 198(12):1053\u20131061","journal-title":"Strahlenther Onkol"},{"key":"2418_CR38","doi-asserted-by":"publisher","first-page":"109604","DOI":"10.1016\/j.radonc.2023.109604","volume":"183","author":"A Fabian","year":"2023","unstructured":"Fabian\u00a0A, Ruhle\u00a0A, Domschikowski\u00a0J, Trommer\u00a0M, Wegen\u00a0S, Becker\u00a0JN et\u00a0al (2023) Financial toxicity in cancer patients undergoing radiotherapy in a\u00a0universal health care system\u2014A prospective multicenter study of 1075 patients. Radiother Oncol 183:109604","journal-title":"Radiother Oncol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-025-02418-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-025-02418-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:52:28Z","timestamp":1765543948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-025-02418-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2418"],"URL":"https:\/\/doi.org\/10.1007\/s00066-025-02418-8","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Trommer, P.\u00a0Gillett, F.\u00a0Franchini, K.\u00a0Trapani, C.\u00a0Hornby, S.\u00a0Abraham, D.\u00a0Herath, K.\u00a0Gough, K.\u00a0Donohoe, P.\u00a0Tran, F.\u00a0Foroudi, M.\u00a0IJzerman and R.\u00a0Khor declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}